PHARMADEVILLE: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PHARMADEVILLE
Largest movements
- Tangible fixed assets +€10,875
up €10,875 (+10.8%), from €100,724 to €111,599
of which Furniture and vehicles: +€21,098
- Stocks and contracts +€9,137
up €9,137 (+11.3%), from €80,639 to €89,776
- Cash -€4,201
down €4,201 (-32.7%), from €12,853 to €8,651
mainly Investment in fixed assets (net) (-€30,762) and Net result for the year (-€17,348)
- Receivables within one year +€2,627
up €2,627 (+5.9%), from €44,351 to €46,979
of which Trade receivables: +€5,761
- Short-term financial debts +€24,000
new in 2025: €24,000
- Profit (loss) carried forward -€17,348
down €17,348, from €9,852 to -€7,496
- Reserves -€15,000
down €15,000 (-29.3%), from €51,237 to €36,237
of which Distributable reserves: -€15,000
- Other debts +€15,000
new in 2025: €15,000
- Current portion of long-term debt +€5,917
up €5,917 (+24.2%), from €24,472 to €30,389
- Gross operating margin -€10,814
down €10,814 (-20.3%), from €53,395 to €42,581
- Depreciation +€9,578
up €9,578 (+92.9%), from €10,308 to €19,886
- Staff costs +€7,164
up €7,164 (+28.5%), from €25,158 to €32,323
- Other operating charges +€1,163
up €1,163 (+64.9%), from €1,794 to €2,957
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €239,033 | €257,934 | +€18,901 | +7.9% |
| Fixed assets | 21/28 | €100,724 | €111,599 | +€10,875 | +10.8% |
| Tangible fixed assets | 22/27 | €100,724 | €111,599 | +€10,875 | +10.8% |
| Land and buildings | 22 | €90,486 | €83,050 | -€7,436 | -8.2% |
| Plant, machinery and equipment | 23 | €10,237 | €7,451 | -€2,786 | -27.2% |
| Furniture and vehicles | 24 | - | €21,098 | +€21,098 | |
| Current assets | 29/58 | €138,309 | €146,335 | +€8,025 | +5.8% |
| Stocks and contracts in progress | 3 | €80,639 | €89,776 | +€9,137 | +11.3% |
| Stocks | 30/36 | €80,639 | €89,776 | +€9,137 | +11.3% |
| Amounts receivable within one year | 40/41 | €44,351 | €46,979 | +€2,627 | +5.9% |
| Trade receivables | 40 | €38,166 | €43,927 | +€5,761 | +15.1% |
| Other amounts receivable | 41 | €6,185 | €3,051 | -€3,134 | -50.7% |
| Cash at bank and in hand | 54/58 | €12,853 | €8,651 | -€4,201 | -32.7% |
| Deferred charges and accrued income | 490/1 | €466 | €929 | +€463 | +99.4% |
| Total equity and liabilities | 10/49 | €239,033 | €257,934 | +€18,901 | +7.9% |
| Equity | 10/15 | €79,681 | €47,332 | -€32,348 | -40.6% |
| Contributions | 10/11 | €18,592 | €18,592 | = | 0.0% |
| Reserves | 13 | €51,237 | €36,237 | -€15,000 | -29.3% |
| Tax-exempt reserves | 132 | €1,243 | €1,243 | = | 0.0% |
| Distributable reserves | 133 | €49,994 | €34,994 | -€15,000 | -30.0% |
| Profit (loss) carried forward | 14 | €9,852 | -€7,496 | -€17,348 | |
| Amounts payable | 17/49 | €159,352 | €210,601 | +€51,249 | +32.2% |
| Amounts payable after more than one year | 17 | €68,865 | €66,138 | -€2,727 | -4.0% |
| Financial debts | 170/4 | €68,865 | €66,138 | -€2,727 | -4.0% |
| Amounts payable within one year | 42/48 | €90,127 | €144,463 | +€54,336 | +60.3% |
| Current portion of amounts payable after more than one year | 42 | €24,472 | €30,389 | +€5,917 | +24.2% |
| Financial debts | 43 | - | €24,000 | +€24,000 | |
| Credit institutions | 430/8 | - | €24,000 | +€24,000 | |
| Trade debts | 44 | €62,680 | €67,900 | +€5,220 | +8.3% |
| Suppliers | 440/4 | €62,680 | €67,900 | +€5,220 | +8.3% |
| Taxes, remuneration and social security | 45 | €2,976 | €7,174 | +€4,198 | +141% |
| Remuneration and social security | 454/9 | €2,976 | €7,174 | +€4,198 | +141% |
| Other amounts payable | 47/48 | - | €15,000 | +€15,000 | |
| Accrued charges and deferred income | 492/3 | €360 | - | -€360 | |
| Remuneration, social security and pensions | 62 | €25,158 | €32,323 | +€7,164 | +28.5% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €10,308 | €19,886 | +€9,578 | +92.9% |
| Other operating charges | 640/8 | €1,794 | €2,957 | +€1,163 | +64.9% |
| Gross operating margin | 9900 | €53,395 | €42,581 | -€10,814 | -20.3% |
| Operating profit (loss) | 9901 | €16,135 | -€12,585 | -€28,720 | |
| Financial income | 75/76B | €42 | €134 | +€92 | +221% |
| Recurring financial income | 75 | €42 | €134 | +€92 | +221% |
| Financial charges | 65/66B | €5,392 | €4,897 | -€495 | -9.2% |
| Recurring financial charges | 65 | €5,392 | €4,897 | -€495 | -9.2% |
| Profit (loss) for the period before taxes | 9903 | €10,784 | -€17,348 | -€28,133 | |
| Profit (loss) for the period | 9904 | €10,784 | -€17,348 | -€28,133 | |
| Profit (loss) for the period to be appropriated | 9905 | €10,784 | -€17,348 | -€28,133 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 18 October 2026 via checked.be.